These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 23187069

  • 1. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.
    Madigan K, Brennan D, Lawlor E, Turner N, Kinsella A, O'Connor JJ, Russell V, Waddington JL, O'Callaghan E.
    Schizophr Res; 2013 Jan; 143(1):138-42. PubMed ID: 23187069
    [Abstract] [Full Text] [Related]

  • 2. A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.
    Barrowclough C, Marshall M, Gregg L, Fitzsimmons M, Tomenson B, Warburton J, Lobban F.
    Psychol Med; 2014 Oct; 44(13):2749-61. PubMed ID: 25065535
    [Abstract] [Full Text] [Related]

  • 3. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C, Montagrin Y, Favrod J, Gibellini S, Conus P.
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [Abstract] [Full Text] [Related]

  • 4. Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis.
    Hjorthøj CR, Orlovska S, Fohlmann A, Nordentoft M.
    Schizophr Res; 2013 Dec; 151(1-3):191-6. PubMed ID: 24189290
    [Abstract] [Full Text] [Related]

  • 5. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ, Velthorst E, Genetic Risk and Outcome of Psychosis (GROUP) Investigators.
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [Abstract] [Full Text] [Related]

  • 6. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
    Toftdahl NG, Nordentoft M, Hjorthøj C.
    J Dual Diagn; 2016 Jul; 12(2):129-36. PubMed ID: 27070732
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M, van der Sluis S, de Haan L.
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [Abstract] [Full Text] [Related]

  • 9. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.
    Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ.
    Addiction; 2009 Mar; 104(3):378-88. PubMed ID: 19207345
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
    Malcolm CP, Picchioni MM, DiForti M, Sugranyes G, Cooke E, Joseph C, McQueen G, Paparelli A, Stilo S, O'Connor J, Morgan C, Murray RM, Hodgins S.
    Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
    [Abstract] [Full Text] [Related]

  • 12. Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial.
    Bonsack C, Gibellini Manetti S, Favrod J, Montagrin Y, Besson J, Bovet P, Conus P.
    Psychother Psychosom; 2011 Mar; 80(5):287-97. PubMed ID: 21646823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F, Verdoux H.
    Encephale; 2002 Mar; 28(2):160-8. PubMed ID: 11972143
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I, Alberich S, Echeburúa E, Aizpuru F, Millán E, Vieta E, Matute C, González-Pinto A.
    PLoS One; 2015 Mar; 10(4):e0123707. PubMed ID: 25875862
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.